Bioscience Methods 2024, Vol.15, No.3, 114-123 http://bioscipublisher.com/index.php/bm 121 7.3 Need for long-term studies and field trials While numerous studies have demonstrated the health benefits of tea and its bioactive compounds, there is a significant need for long-term studies and field trials to validate these findings and assess their practical applications. Most current research is limited to short-term clinical trials or in vitro and in vivo studies, which may not fully capture the long-term effects and real-world applicability of tea consumption (Basu et al., 2011; Sánchez et al., 2020). Long-term studies are particularly important for understanding the chronic effects of tea on metabolic and endocrine disorders, as well as its potential role in disease prevention. Additionally, field trials are necessary to evaluate the effectiveness of metabolic engineering approaches in real-world agricultural settings, ensuring that the enhanced production of bioactive compounds can be achieved sustainably and economically (Wilson and Roberts, 2014). These studies will provide critical insights into the long-term health benefits of tea and the feasibility of implementing metabolic engineering strategies on a larger scale. 8 Concluding Remarks Metabolic engineering has emerged as a powerful tool to enhance the production of bioactive compounds in tea. Various strategies have been explored, including the manipulation of biosynthetic pathways and the use of plant tissue culture techniques. For instance, the production of secondary metabolites, which are crucial for pharmaceutical, cosmetic, and dietary applications, can be significantly increased through metabolic engineering. Additionally, the development of caffeine-free tea through genetic modifications highlights the potential of metabolic engineering to tailor tea's chemical composition for health benefits. The sequencing of the tea tree genome has provided insights into the independent evolution of caffeine biosynthesis and the enhancement of flavonoid metabolic pathways, which are essential for tea flavor and quality. The advancements in metabolic engineering hold significant implications for the tea industry. By enhancing the production of bioactive compounds, tea can be positioned not only as a beverage but also as a functional food with added health benefits. For example, large yellow tea extract has shown potential in ameliorating metabolic syndrome by modulating lipid metabolism and gut microbiota. This opens up new market opportunities for health-oriented tea products. Furthermore, the ability to produce caffeine-free tea through metabolic engineering can cater to consumers who are sensitive to caffeine, thereby expanding the consumer base. The integration of metabolic engineering with traditional tea cultivation practices can lead to the development of high-value tea varieties with improved flavors and health benefits, thereby boosting the economic value of the tea industry. The future of metabolic engineering in tea looks promising, with ongoing research likely to yield even more sophisticated techniques for enhancing bioactive compound production. The integration of systems biology and synthetic biology approaches can further unravel the complexities of tea's metabolic pathways, enabling more precise genetic modifications. Additionally, the use of heterologous hosts for the production of plant natural products can provide scalable and sustainable alternatives to traditional extraction methods. As the field progresses, it is essential to address the challenges related to the predictability and efficiency of genetic transformations to fully realize the potential of metabolic engineering in tea. Overall, the continued advancements in this field are expected to revolutionize the tea industry, making it more versatile and health-oriented. Acknowledgments Thanks to the peer reviewers for their suggestions on this study. Conflict of Interest Disclosure Authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. Reference Alagoz Y., Gurkok T., Zhang B., and Unver T., 2016, Manipulating the biosynthesis of bioactive compound alkaloids for next-generation metabolic engineering in opium poppy using CRISPR-Cas 9 genome editing technology, Scientific Reports, 6: 8. https://doi.org/10.1038/srep30910 Baik J., Shin K., Park Y., Yu K., Suh H., and Choi H., 2015, Biotransformation of catechin and extraction of active polysaccharide from green tea leaves via simultaneous treatment with tannase and pectinase, Journal of the Science of Food and Agriculture, 95(11): 2337-2344.
RkJQdWJsaXNoZXIy MjQ4ODY0NQ==